Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Misoprostol Before Hysteroscopic Resection of Symptomatic Uterine Niches
NCT07271056Completed
- Sponsor
- Benha University
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cesarean scar defect (CSD), abnormal uterine bleeding (AUB) and cesarean section comparing Misoprostol group with Placebo group (2 arms). Primary endpoint: Reduction in number of days of postmenstrual spotting at 3 months. Started Feb 2025; status: completed.
02
Drugs
misoprostol
03
Conditions
cesarean scar defect (CSD)abnormal uterine bleeding (AUB)cesarean section
Beyond the preview
Go deeper on NCT07271056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07271056.